| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |